293 related articles for article (PubMed ID: 9790957)
1. Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration.
Yamamoto T; Kajino K; Ogawa M; Gotoh I; Matsuoka S; Suzuki K; Moriyama M; Okubo H; Kudo M; Arakawa Y; Hino O
Biochem Biophys Res Commun; 1998 Oct; 251(1):339-43. PubMed ID: 9790957
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of TT virus infection and viral integration in human hepatocellular carcinoma].
Yamamoto T; Kajino K; Hino O
Nihon Rinsho; 1999 Jun; 57(6):1370-4. PubMed ID: 10391001
[TBL] [Abstract][Full Text] [Related]
3. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Binelli G; Gelatti U; Portera G; Albertini A; Fasola M; Chiesa R; Nardi G
Hepatology; 1999 Jul; 30(1):294-9. PubMed ID: 10385670
[TBL] [Abstract][Full Text] [Related]
4. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
5. [Detection of TT virus (TTV) in non-B, non-C hepatitis patients with hepatocellular carcinoma, and clinical features of these patients].
Kusama K; Mizuo H; Ikai E; Takahira T
Nihon Rinsho; 1999 Jun; 57(6):1366-9. PubMed ID: 10391000
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of TT virus infection in patients with chronic hepatitis C.
Zein NN; Arslan M; Li H; Charlton MR; Gross JB; Poterucha JJ; Therneau TM; Kolbert CP; Persing DH
Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863
[TBL] [Abstract][Full Text] [Related]
7. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
11. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
12. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis.
Okamoto H; Akahane Y; Ukita M; Fukuda M; Tsuda F; Miyakawa Y; Mayumi M
J Med Virol; 1998 Oct; 56(2):128-32. PubMed ID: 9746068
[TBL] [Abstract][Full Text] [Related]
13. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
14. TT virus infection in chronic liver disease.
Tangkijvanich P; Theamboonlers A; Hirsch P; Kullavanijaya P; Suwangool P; Poovorawan Y
Hepatogastroenterology; 1999; 46(26):1053-8. PubMed ID: 10370666
[TBL] [Abstract][Full Text] [Related]
15. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
Tamori A; Nishiguchi S; Kubo S; Enomoto M; Koh N; Takeda T; Shiomi S; Hirohashi K; Kinoshita H; Otani S
J Med Virol; 2003 Apr; 69(4):475-81. PubMed ID: 12601754
[TBL] [Abstract][Full Text] [Related]
16. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study.
Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y
Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355
[TBL] [Abstract][Full Text] [Related]
17. High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors.
Kato T; Mizokami M; Orito E; Nakano T; Tanaka Y; Ueda R; Hirashima N; Iijima Y; Kato T; Sugauchi F; Mukaide M; Shimamatsu K; Kage M; Kojiro M
J Hepatol; 1999 Aug; 31(2):221-7. PubMed ID: 10453933
[TBL] [Abstract][Full Text] [Related]
18. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
19. [TTV: a new hepatitis virus? Transfusion-transmitted virus].
Cau C
Minerva Med; 1999 Sep; 90(9):339-43. PubMed ID: 10719439
[TBL] [Abstract][Full Text] [Related]
20. Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian survey.
Pineau P; Meddeb M; Raselli R; Qin LX; Terris B; Tang ZY; Tiollais P; Mazzaferro V; Dejean A
J Infect Dis; 2000 Mar; 181(3):1138-42. PubMed ID: 10720542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
